Abstract
Human immunodeficiency virus (HIV) infection is the cause of acquired immunodeficiency syndrome (AIDS). HIV disease continues to be a significant public health problem, although highly active antiretroviral therapy (HAART) has changed the dismal prognosis that existed in the 1980s. Life expectancy for people living with HIV (PLHIV) in the USA has significantly improved in the HAART era. Globally, 5.8 million (16%) PLHIV were older than age 50 years in 2015; the proportion of older PLHIV will rise to 22% in 2020. The burden of the epidemic differs between countries and regions within countries. Sub-Saharan Africa remains most severely affected. Older age with HIV infection presents unique challenges because both older age and HIV disease increases the risk for cardiovascular disease, bone loss, and certain cancers. Older HIV patients have multimorbidity. Opportunistic infections are currently rarer mostly seen in newly diagnosed patients, but drug-related liver toxicities and age-related comorbid conditions have increased. The gastrointestinal (GI) manifestations are rare since the advent of HAART except in individuals not on treatment either because the diagnosis was missed earlier or the treatment was not offered.
Profound involuntary weight loss or wasting (cachexia, a wasting syndrome) indicative of severe protein-energy malnutrition is a frequent complication of AIDS. In HIV, mucosal tissues are the primary sites of viral transmission and significant sites for viral replication. Hence various opportunistic infections, bacterial, viral, and parasitic of the gastrointestinal tract predominate in the clinical manifestations.
References
Aberg JA. Aging, inflammation, and HIV infection. Top Antivir Med. 2012;20(3):101–5.
Alencastro PR, Barcellos NT, Wolff FH, Ikeda MLR, Schuelter-Trevisol F, Brandão ABM, et al. People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study. BMC Res Notes. 2017;10(1):40.
Arora M, Goldberg EM. Kaposi sarcoma involving the gastrointestinal tract. Gastroenterol Hepatol (N Y). 2010;6(7):459–62.
Beeching NJ, Jones R, Gazzard B. 4 gastrointestinal opportunistic infections. HIV Med. 2011;12(s2):43–54.
Bellosta S, Corsini A. Statin drug interactions and related adverse reactions: an update. Expert Opin Drug Saf. 2018;17(1):25–37.
Berretta M, Garlassi E, Cacopardo B, Cappellani A, Guaraldi G, Cocchi S, et al. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist. 2011;16(9):1258–69.
Bhaijee F, Subramony C, Tang S-J, Pepper DJ. Human immunodeficiency virus-associated gastrointestinal disease: common endoscopic biopsy diagnoses. Pathol Res Int. 2011;2011:247923.
Bhattacharya D, Belperio PS, Shahoumian TA, Loomis TP, Goetz MB, Mole LA, et al. Effectiveness of all-oral antiviral regimens in 996 human immunodeficiency virus/hepatitis C virus genotype 1–coinfected patients treated in routine practice. Clin Infect Dis. 2017;64(12):1711–20.
Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.–Canadian multicenter study. J Hepatol. 2007;47(4):527–37.
Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008;1:23–30.
Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200(6):749–59.
Brugnaro P, Morelli E, Cattelan F, Petrucci A, Panese S, Eseme F, et al. Non-AIDS definings malignancies among human immunodeficiency virus-positive subjects: epidemiology and outcome after two decades of HAART era. World J Virol. 2015;4(3):209–18.
Cañizares S, Cherner M, Ellis RJ. HIV and aging: effects on the central nervous system. Semin Neurol. 2014;34(1):27–34.
Cardoso SW, Torres TS, Santini-Oliveira M, Marins LMS, Veloso VG, Grinsztejn B. Aging with HIV: a practical review. Braz J Infect Dis. 2013;17(4):464–79.
Cello JP, Day LW. Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology. 2009;136(6):1952–65.
Centers for Disease Control and Prevention. HIV basics. Centers for Disease Control and Prevention; 2015. p. 1. Atlanta, Georgia, USA.
Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2015. HIV Surveill Rep [Internet]. 2016;27. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2015-vol-27.pdf
Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2016 [Internet]. Vol. 28, HIV Surveillance Report. 2017. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html; http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html; http://wwwn.cdc.gov/dcs/ContactUs/Form
Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2015 [Internet]. Vol. 23, HIV Surveillance Supplemental Report. 2018. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html; http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html; http://wwwn.cdc.gov/dcs/ContactUs/Form
Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons living with diagnosed hiv infection – medical monitoring project, United States, 2015 Cycle [Internet]. 2019. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html; https://www.cdc.gov/hiv/pdf/statistics/systems/mmp/cdc-hiv-mmp-project-area-group-members-2015.pdf
Cervera JL, Ramirez LES, Poo JL, Uribe M. Hepatobiliary diseases in patients with human immunodeficiency virus (HIV) treated with non highly active anti-retroviral therapy: frequency and clinical manifestations. Ann Hepatol. 2005;4:188–91.
Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS. 2006;20:2371–9.
Chen YN, Wall KM, Fofana K, Navarro-Colorado C. Nutrition indicators as potential predictors of AIDS-defining illnesses among ARV-naïve HIV-positive adults in Kapiri Mposhi, Zambia 2008–2009. PLoS One. 2019;14(7):e0219111.
Chung RT, Davis GL, Jensen DM, Masur H, Saag MS, Thomas DL, et al. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62:932–54.
Coghill AE, Shiels MS, Suneja G, Engels EA. Elevated cancer-specific mortality among HIV-infected patients in the United States. J Clin Oncol. 2015;33(21):2376–83.
Dai Y-N, Ren Z-Z, Song W-Y, Huang H-J, Yang D-H, Wang M-S, et al. Peliosis hepatis: 2 case reports of a rare liver disorder and its differential diagnosis. Medicine (Baltimore). 2017;96(13):e6471.
De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, Narita M, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood J. 2004;103(6):2180–6.
Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2009. Washington DC, USA.
Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol Ser A Biol Sci Med Sci. 2007;62(11):1279–86.
Devarbhavi H, Sebastian T, Seetharamu SM, Karanth D. HIV/AIDS cholangiopathy: clinical spectrum, cholangiographic features and outcome in 30 patients. J Gastroenterol Hepatol [Internet]. 2010;25(10):1656–60. http://www.ncbi.nlm.nih.gov/pubmed/20880175
Didier ES, Weiss LM. Microsporidiosis: current status. Curr Opin Infect Dis. 2006;19(5):485–92.
Dragovic G. Acute pancreatitis in HIV/AIDS patients: an issue of concern. Asian Pac J Trop Biomed. 2013;3(6):422–5.
Ehren K, Hertenstein C, Kümmerle T, Vehreschild JJ, Fischer J, Gillor D, et al. Causes of death in HIV-infected patients from the Cologne–Bonn cohort. Infection. 2014;42(1):135–40.
Ehrenpreis ED. Small intestinal manifestations of HIV infection. Int J STD AIDS. 1995;6(3):149–55.
Engels EA, Clark E, Aledort LM, Goedert JJ, Whitby D. Kaposi’s sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from new York City. Int J Epidemiol. 2002;31(5):946–50.
Erlandson KM, Allshouse AA, Rapaport E, Palmer BE, Wilson CC, Weinberg A, et al. Physical function impairment of older, HIV-infected adults is associated with cytomegalovirus immunoglobulin response. AIDS Res Hum Retrovir. 2015;31(9):905–12.
Gazzard B, Marie Girard P, Di Perri G, Gallant J, Towner W, Rogatto F, et al. Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years. J Int AIDS Soc. 2014;17:19767.
Gotti D, Raffetti E, Albini L, Sighinolfi L, Maggiolo F, Di Filippo E, et al. Survival in HIV-infected patients after a cancer diagnosis in the cART era: results of an Italian multicenter study. PLoS One. 2014;9(4):e94768.
Greene M, Covinsky KE, Valcour V, Miao Y, Madamba J, Lampiris H, et al. Geriatric syndromes in older HIV-infected adults. J Acquir Immune Defic Syndr. 2015;69(2):161–7.
Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. J Clin Pathol. 2007;60(12):1365–72.
Haines CF, Moore RD, Bartlett JG, Sears CL, Cosgrove SE, Carroll K, et al. Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS. 2013;27(17):2799–807.
Herman JS, Easterbrook PJ. The metabolic toxicities of antiretroviral therapy. Int J STD AIDS. 2001;12:555–64.
High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH office of AIDS research by the HIV and aging working group. J Acquir Immune Defic Syndr. 2012;60(Suppl 1):S1–18.
Ingiliz P, Mayr C, Obermeier M, Herbst H, Polywka S, Pischke S. Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient. Clin Res Hepatol Gastroenterol. 2016;40(3):e23–5.
Izzedine H, Harris M, Perazella MA. The nephrotoxic effects of HAART. Nat Rev Nephrol. 2009;5:563–73.
Jensen BE-O, Oette M, Haes J, Häussinger D. HIV-associated gastrointestinal cancer. Oncol Res Treat. 2017;40(3):115–8.
Kalayjian RC, Landay A, Pollard RB, Taub DD, Gross BH, Francis IR, et al. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003;187:1924.
Katabira ET. Epidemiology and management of diarrheal disease in HIV-infected patients. Int J Infect Dis. 1999;3(3):164–7.
Kautz T, Bendavid E, Bhattacharya J, Miller G. AIDS and declining support for dependent elderly people in Africa: retrospective analysis using demographic and health surveys. BMJ. 2010 Jun;340:c2841.
Kohli R, Klein RS, Schoenbaum EE, Anastos K, Minkoff H, Sacks HS. Aging and HIV infection. J Urban Health. 2006 Jan;83(1):31–42.
Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005;19(6):593–601.
Kovari H, Weber R. Influence of antiretroviral therapy on liver disease. Curr Opin HIV AIDS. 2011;6(4):272–7.
Krishnan KRR, Delong M, Kraemer H, Carney R, Spiegel D, Gordon C, et al. Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry. 2002;52(6):559–88.
Lew EA, Poles MA, Dieterich DT. Diarrheal diseases associated with HIV infection. Gastroenterol Clin N Am. 1997;26(2):259–90.
Macarthur RD. Management of noninfectious diarrhea associated with HIV and highly active antiretroviral therapy. Am J Manag Care. 2013;19(12 Suppl):s238–45.
MacArthur RD, DuPont HL. Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era. Clin Infect Dis. 2012;55(6):860–7.
Mahajani RV, Uzer MF. Cholangiopathy in HIV-infected patients. Clin Liver Dis. 1999;3(3):669–84.
Mangili A, Murman DH, Zampini AM, Wanke CA, Mayer KH. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis. 2006;42(6):836–42.
Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet. 2004;364(9443):1428–34.
Mitsch A, Singh S, Li J, Balaji A, Linley L, Selik R. Age-associated trends in diagnosis and prevalence of infection with HIV among men who have sex with men – United States, 2008–2016. MMWR Morb Mortal Wkly Rep [Internet]. 2018;67(37):1025–31. http://www.cdc.gov/mmwr/volumes/67/wr/mm6737a2.htm?s_cid=mm6737a2_w
Mohapatra S, Singh DP, Alcid D, Pitchumoni CS. Beyond O&P times three. Am J Gastroenterol. 2018;113(6):805–18.
Murray JA, Rubio-Tapia A. Diarrhoea due to small bowel diseases. Best Pract Res Clin Gastroenterol. 2012;26(5):581–600.
Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W, Hong SY, et al. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets. 2011;11(2):167–74.
Nachega JB, Hsu AJ, Uthman OA, Spinewine A, Pham PA. Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population. AIDS. 2012;26(suppl. 1):S39–53.
Naseer M, Dailey FE, Juboori A, Samiullah S, Tahan V. Epidemiology, determinants, and management of AIDS cholangiopathy: a review. World J Gastroenterol. 2018;24(7):767–74.
Neff GW, Jayaweera D, Sherman KE. Drug-induced liver injury in HIV patients. Gastroenterol Hepatol. 2006;2(6):430–7.
Neill MA, Rice SK, Ahmad NV, Flanigan TP. Cryptosporidiosis: an unrecognized cause of diarrhea in elderly hospitalized patients. Clin Infect Dis. 1996;22:168–70.
Núñez M, Lana R, Mendoza JL, Martín-Carbonero L, Soriano V. Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;27(5):426–31.
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338(13):853–60.
Parvin R, Kolli S, Shah J, Jhaveri M, Reddy M. Upper and lower gastrointestinal endoscopic findings in HIV-infected patients in the era of highly active antiretroviral therapy. Gastroenterol Res. 2018;11(2):95–9.
Poles MA, Dieterich DT, Schwarz ED, Weinshel EH, Lew EA, Lew R, et al. Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV). J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11(2):170–7.
Price JC, Thio CL. Liver disease in the HIV–infected individual. Clin Gastroenterol Hepatol. 2010;8(12):1002–12.
Rajasuriar R, Chong ML, Ahmad Bashah NS, Abdul Aziz SA, Mcstea M, Lee ECY, et al. Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy. AIDS. 2017;31(10):1393–403.
Rathi PM, Amarapurkar DN, Borges NE, Koppikar GV, Kalro RH. Spectrum of liver diseases in HIV infection. Indian J Gastroenterol. 1997;16(3):94–5.
Rickabaugh TM, Jamieson BD. A challenge for the future: aging and HIV infection. Immunol Res. 2010;48:59–71.
Rodriguez-Mendez ML, Gonzalez-Quintela A, Aguilera A, Barrio E. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am J Gastroenterol. 2000;95(5):1316–22.
Roser M, Ritchie H. HIV/AIDS [Internet]. Our world in data. 2018 [cited 2019 July 10]. https://ourworldindata.org/hiv-aids
Sandrasegaran K, Hawes DR, Matthew G. Hepatic peliosis (bacillary angiomatosis) in AIDS: CT findings. Abdom Imaging. 2005;30(6):738–40.
Sanga Y, Diallo I, Meda N, Ouédraogo S, Poda A, Hema A, et al. Profiles of elderly people infected with HIV and response to antiretroviral treatment in Burkina Faso : a retrospective cohort study. J Curr Res HIV/AIDS. 2016;1:6.
Shapiro JM, Braun NMT. Fatal lactic acidosis and hepatic Steatosis due to combination nucleoside analog therapy for HIV infection. J Intensive Care Med. 1999;14(6):275–8.
Sievert W, La Brooy JT. HIV-related gastrointestinal disease. Med J Aust. 1993;158(3):175–8.
Sivapalasingam S, Blaser MJ. Bacterial diarrhea in HIV-infected patients: why Clostridium difficile, and why now? Clin Infect Dis. 2005;41(11):1628–30.
Thirumurthy H, Zivin JG, Goldstein M. The economic impact of AIDS treatment: labor supply in Western Kenya. J Hum Resour. 2008;43(3):511–52.
Tsoukas C. Immunosenescence and aging in HIV. Curr Opin HIV AIDS. 2014;9:398–404.
Van Epps P, Kalayjian RC. Human immunodeficiency virus and aging in the era of effective antiretroviral therapy. Infect Dis Clin N Am. 2017;31(4):791–810.
Von Roenn JH. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia. Oncology. 1994;51(Suppl. 1):19–24.
Wang H, Kotler DP. HIV enteropathy and aging. Curr Opin HIV AIDS. 2014;9(4):309–16.
Wang Z-D, Liu Q, Liu H-H, Li S, Zhang L, Zhao Y-K, et al. Prevalence of cryptosporidium, microsporidia and isospora infection in HIV-infected people: a global systematic review and meta-analysis. Parasit Vectors. 2018;11(1):28.
Wing EJ. HIV and aging. Int J Infect Dis. 2016;53:61–8.
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. Morb Mortal Wkly Rep [Internet]. 2015. https://www.cdc.gov/mmwr/pdf/rr/rr6403.pdf
Yeni P. Update on HAART in HIV. J Hepatol. 2006;44:S100–3.
Zingmond DS, Kilbourne AM, Justice AC, Wenger NS, Rodriguez-Barradas M, Rabeneck L, et al. Differences in symptom expression in older HIV-positive patients: the veterans aging cohort 3 site study and HIV cost and service utilization study experience. J Acquir Immune Defic Syndr. 2003;33(Suppl 2):S84–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Pitchumoni, C.S., Desai, M.A. (2021). HIV in Older Adults. In: Pitchumoni, C.S., Dharmarajan, T. (eds) Geriatric Gastroenterology. Springer, Cham. https://doi.org/10.1007/978-3-030-30192-7_91
Download citation
DOI: https://doi.org/10.1007/978-3-030-30192-7_91
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30191-0
Online ISBN: 978-3-030-30192-7
eBook Packages: MedicineReference Module Medicine